9 | Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2016
-
02/2012 |
6 | Haloperidol (Haldol)FDA LinkGeneric
01/2016
-
11/2011 |
4 | Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2017
-
06/2012 |
3 | 1-dodecylpyridoxal (PLD)IBA
12/2014
-
09/2010 |
3 | Metabotropic Glutamate 5 ReceptorIBA
07/2014
-
10/2013 |
3 | Oxygen (Dioxygen)IBA
04/2013
-
11/2004 |
3 | Bortezomib (Velcade)FDA Link
12/2006
-
06/2005 |
2 | Analgesics (Analgesic Drugs)IBA
05/2019
-
01/2019 |
2 | VU0466551IBA
05/2019
-
01/2019 |
2 | Morphine (MS Contin)FDA LinkGeneric
05/2019
-
01/2019 |
2 | Biomarkers (Surrogate Marker)IBA
01/2017
-
04/2006 |
2 | N-Methylaspartate (NMDA)IBA
03/2016
-
05/2015 |
2 | Glutamate Receptors (Glutamate Receptor)IBA
03/2016
-
05/2015 |
2 | Levodopa (L Dopa)FDA LinkGeneric
01/2016
-
02/2012 |
2 | metabotropic glutamate receptor 4IBA
01/2016
-
01/2016 |
2 | Proteins (Proteins, Gene)FDA Link
01/2016
-
07/2015 |
2 | EnzymesIBA
11/2015
-
11/2004 |
2 | Amphetamine (Amfetamine)FDA LinkGeneric
03/2015
-
07/2014 |
2 | Tirapazamine (SR 4233)IBA
10/2007
-
11/2004 |
2 | DNA (Deoxyribonucleic Acid)IBA
10/2007
-
11/2004 |
2 | Proteasome InhibitorsIBA
04/2006
-
06/2005 |
2 | Boronic AcidsIBA
04/2006
-
06/2005 |
1 | Psychotropic Drugs (Psychoactive Drugs)IBA
11/2019 |
1 | Opioid Analgesics (Opioids)IBA
01/2019 |
1 | Opioid Receptors (Opioid Receptor)IBA
01/2019 |
1 | 2-(aminomethyl)phenolIBA
11/2018 |
1 | Methyl-CpG-Binding Protein 2IBA
01/2017 |
1 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
11/2016 |
1 | 5- amino- 3,4- dimethyl- N- (4- ((trifluoromethyl)sulfonyl)benzyl)thieno(2,3- c)pyridazine- 6- carboxamideIBA
03/2016 |
1 | Clozapine (Clozaril)FDA LinkGeneric
03/2016 |
1 | Hypnotics and Sedatives (Sedatives)IBA
03/2016 |
1 | Dizocilpine Maleate (Dizocilpine)IBA
03/2016 |
1 | Therapeutic UsesIBA
01/2016 |
1 | Antiparasitic Agents (Antiparasitics)IBA
11/2015 |
1 | AzolesIBA
11/2015 |
1 | Cadherins (E-Cadherin)IBA
10/2015 |
1 | piperidineIBA
07/2015 |
1 | VU0409551IBA
06/2015 |
1 | Exenatide (Byetta)FDA Link
12/2014 |
1 | VU0468809IBA
12/2014 |
1 | Antiviral Agents (Antivirals)IBA
12/2014 |
1 | Phospholipase DIBA
09/2014 |
1 | Glutamic Acid (Glutamate)FDA Link
07/2014 |
1 | Cytochrome P-450 CYP3AIBA
12/2013 |
1 | Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
09/2013 |
1 | VU0463841IBA
08/2013 |
1 | Cocaine (Cocaine HCl)IBA
08/2013 |
1 | Oxidoreductases (Dehydrogenase)IBA
04/2013 |
1 | ProdrugsIBA
04/2013 |
1 | ML299IBA
03/2013 |
1 | decaneIBA
03/2013 |
1 | 3,4- difluoro- N- (2- (1- (3- fluorophenyl)- 4- oxo- 1,3,8- triazaspiro(4.5)decan- 8- yl)ethyl)benzamideIBA
03/2013 |
1 | ProstaglandinsIBA
01/2013 |
1 | Prostaglandins EIBA
01/2013 |
1 | ML253IBA
01/2013 |
1 | benzocycloheptapyridineIBA
01/2013 |
1 | compound 17IBA
01/2013 |
1 | Oxidopamine (6 Hydroxydopamine)IBA
02/2012 |
1 | N-(3-chlorophenyl)picolinamideIBA
02/2012 |
1 | 2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA
02/2012 |
1 | Adenosine (Adenocard)FDA LinkGeneric
02/2012 |
1 | T-Type Calcium Channels (T-Type Calcium Channel)IBA
12/2011 |
1 | Protein Isoforms (Isoforms)IBA
09/2010 |